Daxor Corp (DXR) CFO discloses 3,000-share stock grant in Form 4 filing

Rhea-AI Filing Summary

Daxor Corp reported an insider equity transaction by its Chief Financial Officer, Robert J. Michel. On December 9, 2025, he acquired 3,000 shares of Daxor common stock at a stated price of $0, reflecting the vesting of a stock grant.

Following this transaction, the CFO beneficially owns 20,050 shares of Daxor common stock in direct ownership, according to the Form 4 disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Michel Robert J

(Last) (First) (Middle)

109 MECO LANE

(Street)

OAK RIDGE, TN 37830

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DAXOR CORP [ DXR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Daxor Common Stock	12/09/2025		P		3,000(1)	A	$0	20,050	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 3,000 shares granted vest on December 9, 2025.

	/s/ Robert J. Michel	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Daxor (DXR) disclose in this Form 4?

The filing shows that Chief Financial Officer Robert J. Michel acquired 3,000 shares of Daxor common stock on December 9, 2025, due to the vesting of a stock grant at a stated price of $0.

How many Daxor (DXR) shares does the CFO own after this transaction?

After the reported grant vested, the CFO beneficially owns 20,050 shares of Daxor common stock, held in direct ownership.

Who is the reporting person in this Daxor (DXR) Form 4 filing?

The reporting person is Robert J. Michel, who serves as Chief Financial Officer of Daxor Corp.

What was the price associated with the 3,000 Daxor (DXR) shares acquired?

The 3,000 Daxor common shares were reported as acquired at a stated price of $0, consistent with a vested stock grant rather than an open-market purchase.

Does this Daxor (DXR) Form 4 report any derivative securities transactions?

The section for derivative securities is present but shows no reported acquisitions or dispositions, indicating no derivative securities transactions in this filing excerpt.

What is the transaction code used for the Daxor (DXR) insider transaction?

The Form 4 lists transaction code P for the December 9, 2025 acquisition of 3,000 shares, alongside an explanation that the shares were granted and vested on that date.